SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Broadfin Capital, LLC

CIK 0001511901 · 300 PARK AVENUE, 25TH FLOOR, NEW YORK, NY, 10022 · 212-808-2460

Reported Value
$541M
Q3 2019
Positions
44
Filings on Record
5
2019–present window
Filed
Nov 14, 2019
original filing

Summary

Broadfin Capital, Llc reported $541M in U.S.-listed holdings across 44 positions for Q3 2019.

Its largest position, Amarin, represents 4.4% of the portfolio.

Compared with Q2 2019, the fund opened 14 new positions and exited 7.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $761MQ4 ’18Q1 ’19: $484MQ1 ’19Q2 ’19: $460MQ2 ’19Q3 ’19: $541MQ3 ’19Q4 ’19: $747MQ4 ’19filingsflow.com

Portfolio Composition

By security type
Common Stock: 41.2%ETP: 34.0%Other: 24.1%ADR: 0.6%
  • Common Stock · 41.2% · $223M
  • ETP · 34.0% · $184M
  • Other · 24.1% · $131M
  • ADR · 0.6% · $3M

Quarter-over-Quarter Changes full breakdown →

Holdings — Q3 2019

Loading…
Export to Excel
#IssuerClass% PortfolioValue ↓Shares

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2019$747M40Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$541M44Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$460M39Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$484M43May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$761M50Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • Broadfin Healthcare Master Fund Ltd28-14254

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.